Longueuil, Quebec, Canada – MENODYS is initiating a first in human clinical proof of concept with its innovative Scar Appearance Minimizing Device in patients undergoing an abdominoplasty. MENODYS has selected the Montreal Health Innovations Coordinating Center (MHICC), a division of the Montreal Heart Institute and Q&T Research, Sherbrooke, Quebec to coordinate this clinical trial to test MENODYS’ technology in 15 patients. Dr. Michel Chagnon, MD, FRCP, general surgeon, will be the principal investigator for this study. The primary objective of the study is to evaluate the benefits of the MENODYS’ device in minimizing the appearance of a scar over a period of 8 weeks of treatment with the device.
MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com
Founded in 1954 by Dr. Paul David, the Montreal Heart Institute constantly aims for the highest standards of excellence in the cardiovascular field through its leadership in clinical and basic research, ultra-specialized care, professional training and prevention. It is part of the broad network of health excellence made up of Université de Montréal and its affiliated institutions. The Montreal Health Innovations Coordinating Centre (MHICC), a division of the MHI, is a full service clinical academic research organization, providing services to the academic community and to the pharmaceutical, biotechnology and medical device industries, in the fields of cardiology, neurology, oncology, dermatology, endocrinology and pharmacogenomics. www.icm-hi.org www.micc.org
Q&T Research is an independent clinical research site with a robust expertise in Phase II-III vaccines, blood derivatives for immuno markers, moderate to severe psoriasis, Alzheimer, COPD and women/men health. The research group is made of 6 research nurses, 8 physicians, 2 lab technicians, 1 research assistant and 1 pharmacist. The group aims at reaching high quality of information gathered, meeting the recruitment target and respecting the mutually agreed timelines. www.qtresearch.com